Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Evaluation of the potential perpetrator effect of BAY1841788 (ODM-201) on rosuvastatin pharmacokinetics.
PK of BAY1841788 (ODM-201) after single and repeated administration in male and female subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Medical and surgical history
History of myopathia after treatment with statins.
30 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal